Duration of adrenal inhibition following a single dose of etomidate in critically ill patients - Wikidata - awgldk - TriplyDB

Duration of adrenal inhibition following a single dose of etomidate in critically ill patients

Duration of adrenal inhibition following a single dose of etomidate in critically ill patients

http://www.wikidata.org/entity/Q28261624

about

Single induction dose of etomidate versus other induction agents for endotracheal intubation in critically ill patients Etomidate in pediatric anesthesiology: Where are we now?Updates on the role of adrenal steroidogenesis inhibitors in Cushing's syndrome: a focus on novel therapies [Perioperative Addisonian crisis].Evidence and consensus-based German guidelines for the management of analgesia, sedation and delirium in intensive care--short version.Carboetomidate: a pyrrole analog of etomidate designed not to suppress adrenocortical function Etomidate as an induction agent in septic patients: red flags or false alarms?Advantages and disadvantages of etomidate use for intubation of patients with sepsis.Advancing novel anesthetics: pharmacodynamic and pharmacokinetic studies of cyclopropyl-methoxycarbonyl metomidate in dogs.Anesthetic drug development: Novel drugs and new approaches.Clinical and molecular pharmacology of etomidate.High serum cortisol level is associated with increased risk of delirium after coronary artery bypass graft surgery: a prospective cohort study.Closed-loop continuous infusions of etomidate and etomidate analogs in rats: a comparative study of dosing and the impact on adrenocortical function Steroidogenesis in the adrenal dysfunction of critical illness: impact of etomidate Effects of etomidate on complications related to intubation and on mortality in septic shock patients treated with hydrocortisone: a propensity score analysis Etomidate for intubation of patients who have sepsis or septic shock--where do we go from here?Methoxycarbonyl-etomidate: a novel rapidly metabolized and ultra-short-acting etomidate analogue that does not produce prolonged adrenocortical suppression.Effects of etomidate on adrenal suppression: a review of intubated septic patients.The effect of etomidate on adrenal function in critical illness: a systematic review.The pharmacology of airway management in critical care.Glucocorticoids in sepsis: dissecting facts from fiction.Rapid-sequence intubation: a review of the process and considerations when choosing medications.Video laryngoscopy versus direct laryngoscopy for orotracheal intubation in the intensive care unit: a systematic review and meta-analysis.Etomidate--a review of robust evidence for its use in various clinical scenarios.Suspected adrenal insufficiency in critically ill burned patients: etomidate-induced or critical illness-related corticosteroid insufficiency?-A review of the literature.Effect of Etomidate on Pneumonia Development in Critically Ill, Nontrauma Patients.The role of etomidate as an anaesthetic induction agent for critically ill patients.The use of a low dose hydrocortisone to prevent pulmonary embolism in patients with multiple trauma.Comparison of Etomidate and Ketamine for Induction During Rapid Sequence Intubation of Adult Trauma Patients.Cosyntropin as a diagnostic agent in the screening of patients for adrenocortical insufficiency.Device and Medication Preferences of Canadian Physicians for Emergent Endotracheal Intubation in Critically Ill Patients.Low-dose hydrocortisone reduces norepinephrine duration in severe burn patients: a randomized clinical trial.Septic shock and anesthesia: Much ado about nothing?Pro-con debate: etomidate or ketamine for rapid sequence intubation in pediatric patients.Does etomidate increase vasopressor requirements in patients needing mechanical ventilation?Letter to the editor: Hypotension after etomidate use in sepsis.Sedative-hypnotic Binding to 11β-hydroxylase.Is etomidate really that bad in septic patients?Etomidate in sepsis: understanding the dilemma.Analgosedation of adult patients with elevated intracranial pressure : Survey of current clinical practice in Austria.

P2860

Q24186699-0B6E8067-ED73-470D-A607-5B6E53655645 Q26778878-F68EE3BE-8067-4B53-B2CD-04B0C465026A Q28076013-51BEDC15-CE82-4E38-A23D-C8A58D7DAE30 Q30318070-1A6287C5-546B-4268-B36C-15637D932166 Q33696421-C13AAD29-9796-4345-84BC-DCC63A5FAC1B Q33697203-C3FB18F1-2565-4326-9435-65BEEEA05170 Q34014209-131E0E90-37DF-4739-9E62-DB5C0701275A Q34266921-8A2AE851-38E8-4024-BCD6-448A94E29E7E Q34543679-CAADE0FB-22BD-492D-9055-B419E378869E Q34710067-6E8C8746-A482-4783-9DEF-204735DA6916 Q35024852-132EACAA-06DC-41E9-A3CB-3EAA6218EA0C Q35561202-273905BE-4F37-44E2-8456-042AB97608AC Q36501060-AB8114BF-D272-41B1-AEA5-B034E88C136B Q36633846-9C38381F-8A91-4F72-A240-A930A2B8BF80 Q36902778-F7F92D18-3591-4DA2-95A1-0BB741067574 Q36902809-CA496D73-EBE0-4E8B-9EF0-C44F8C228B17 Q37336611-8C3EB7C4-4408-49C9-90A1-648DDC659081 Q37614154-FDDCD199-1529-4723-8B4B-8F841212FDDB Q37849626-E3F558BB-BDAB-4178-ABA7-2A768317F234 Q37857544-F47E74C8-BB1A-4F14-82A7-B9E03BFD993C Q37876499-B5CC27C1-018A-4A84-B181-7A9C446062C4 Q38164669-6413D0EF-14D1-4D9E-85BE-28B26661E2D5 Q38189977-CA9D7C40-A2B2-47E6-B1B5-D799D0EAC538 Q38192677-478E5395-654E-42BB-AB37-873306B6079F Q38233162-78BA848A-61E3-45A4-90D4-6F200A217992 Q38403594-240F06D4-0D34-4066-960D-9D8C80ECA92D Q38831520-5F431150-6B61-46A5-8AD9-98BC50A108D0 Q38936452-32C04055-500C-46E1-AE43-86CA59EA9C06 Q40417665-9D7A1AF2-E866-4397-B0F0-7A4B330517B1 Q40541106-69C3577C-7946-4D66-8358-EA828D822BAF Q40602633-CE2B305D-C642-4D10-A076-DCF4347DE9A0 Q41523340-15568A3F-AA27-4DF7-A1A6-24E33E13F410 Q41859340-C9523759-16F1-4CAC-A8BC-4CB3EFA8F395 Q41917799-CF92BC81-042A-4284-A986-C3434875192D Q42279385-D653B7E4-1696-4B87-96C1-BB6138624727 Q42630448-AD792442-06D7-4D6B-AF51-531A3540E4AC Q42707315-1AC9335F-D20B-41BC-B5C7-5F5CF8A2C467 Q43092591-AB4E4EAB-71BB-4B7B-BB74-2DCB1BF56E08 Q43185781-BC9AFD4A-3081-4D2E-A008-3794C8820F68 Q47271373-6CC33B9C-5685-4DA7-ACED-A8AEAB6001B5

P2860

Duration of adrenal inhibition following a single dose of etomidate in critically ill patients

http://www.wikidata.org/entity/Q28261624

description

2008 nî lūn-bûn

@nan

2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Duration of adrenal inhibition ...... ate in critically ill patients

@ast

Duration of adrenal inhibition ...... ate in critically ill patients

@en

Duration of adrenal inhibition ...... ate in critically ill patients

@nl

type

label

Duration of adrenal inhibition ...... ate in critically ill patients

@ast

Duration of adrenal inhibition ...... ate in critically ill patients

@en

Duration of adrenal inhibition ...... ate in critically ill patients

@nl

prefLabel

Duration of adrenal inhibition ...... ate in critically ill patients

@ast

Duration of adrenal inhibition ...... ate in critically ill patients

@en

Duration of adrenal inhibition ...... ate in critically ill patients

@nl

P1433

Q28261624-FC768509-CB0B-4149-9D49-D50B39085589

P1476

Q28261624-2B8DD4B8-1299-4F56-89E4-298F6E9FC96C

P2093

Q28261624-0A95917B-C8D1-4EC5-88AB-0A6AA52FB337

Q28261624-186DD3AF-40E5-4A19-A342-2671E0327015

Q28261624-33601E02-C5A1-44B5-B693-9D50423F6E52

Q28261624-BA403F0D-1630-4E65-9115-EB7001BF0297

Q28261624-D0BDE7BB-388A-4EB9-B274-D2668976BC44

Q28261624-F1F2BA59-0AB3-4559-878C-8EF2DC5964B2

Q28261624-FA22705A-1CB0-42AB-BEA9-665375304086

P2888

Q28261624-2922AD8A-F663-4A42-A45F-9810C316B506

P304

Q28261624-F655DBA6-4160-4EC3-A914-5F5F0376DE00

P31

Q28261624-FFB8948F-3C0F-46A1-88FF-A9DB89916026

P3181

Q28261624-B3489EAD-D70E-41C5-93B0-5E84BB1A3F54

P356

Q28261624-5B4181C3-D3DA-4572-BF6E-EC45F5ED5D7B

P407

Q28261624-69F31381-CC93-4EDC-B387-2705D0BBEBB6

P433

Q28261624-969BF479-5FE7-4A70-B9BC-C85E09ACA7F9

P478

Q28261624-0A58EBD3-480A-44D6-B5B5-320A7E6EC0FF

P50

Q28261624-F87DDF53-9488-45EE-970F-393928F2397D

P577

Q28261624-C9BD9A57-1C31-40AB-BFF9-81812AAA3EA5

P5875

Q28261624-CDFB66E5-0F02-41AC-B5D7-1CFB33962607

P698

Q28261624-00BA45A7-9144-4ACF-A6C1-D2F555E8348A

P921

Q28261624-98E5BFFA-D704-4C23-9902-9B54464D6163

P3181

P356

S00134-007-0970-Y

P1433

Intensive Care Medicine

P1476

Duration of adrenal inhibition ...... ate in critically ill patients

@en

P2093

Christophe Broux

http://www.w3.org/2001/XMLSchema#string

Claude Jacquot

http://www.w3.org/2001/XMLSchema#string

Céline Genty

http://www.w3.org/2001/XMLSchema#string

Jean-François Payen

http://www.w3.org/2001/XMLSchema#string

Julien Brun

http://www.w3.org/2001/XMLSchema#string

Marc Vinclair

http://www.w3.org/2001/XMLSchema#string

Patrice Faure

http://www.w3.org/2001/XMLSchema#string

P2888

s00134-007-0970-y

P304

714-719

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3663800

http://www.w3.org/2001/XMLSchema#string

P356

10.1007/S00134-007-0970-Y

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-12-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5757157

http://www.w3.org/2001/XMLSchema#string

P698

18092151

http://www.w3.org/2001/XMLSchema#string

P921